Mark Paul Donahue

Conference · 2017 Introduction: It is unclear whether multi-marker approaches improve risk stratification among patients with heart failure (HF). We evaluated the prognostic utility of a multi-marker approach with biomarkers of HF status; Growth-differentiation factor-15 (G ... Cite

Prognostic Utility of GDF-15 in Chronic Heart Failure: Insights From the HF-ACTION Study

Conference EUROPEAN HEART JOURNAL · August 1, 2016 Link to item Cite

INCORPORATION OF GUIDELINE DATA INTO ORDERING SYSTEMS REDUCES TRANSTHORACIC ECHOCARDIOGRAPHY ORDER FREQUENCY

Conference JOURNAL OF GENERAL INTERNAL MEDICINE · April 1, 2015 Link to item Cite

ADRENERGIC RECEPTOR POLYMORPHISMS INTERACT WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES ESPECIALLY IN BLACK RACE: RESULTS FROM HF-ACTION DNA SUBSTUDY

Conference Journal of the American College of Cardiology · March 2015 Full text Cite

ALPHA-2C ADRENERGIC RECEPTOR POLYMORPHISM INTERACTS WITH BETA-BLOCKER DOSE EFFECT ON HEART FAILURE OUTCOMES DIFFERENTLY IN BLACK RACE: RESULTS FROM THE HF-ACTION DNA SUBSTUDY

Conference Journal of the American College of Cardiology · March 2015 Full text Cite

Incremental Prognostic Utility by Cost and Complexity in Chronic Heart Failure

Conference CIRCULATION · November 26, 2013 Link to item Cite

Association of Small Molecule Metabolic Intermediates that Predict Cardiovascular Mortality with Peak VO2 in a Heart Failure Population

Conference CIRCULATION · March 26, 2013 Link to item Cite

RELATIONSHIP BETWEEN EXERCISE TRAINING AND CHANGES IN BIOMARKERS OF MYOCARDIAL STRESS, INJURY AND INFLAMMATION IN PATIENTS WITH CHRONIC HEART FAILURE

Conference Journal of the American College of Cardiology · March 2013 Full text Cite

INTERACTION BETWEEN ST2 LEVELS AND EXERCISE TRAINING IN PATIENTS WITH CHRONIC HEART FAILURE: ANALYSIS FROM THE HF-ACTION TRIAL

Conference Journal of the American College of Cardiology · March 2012 Full text Cite

Prognostic value of Galectin-3 in chronic heart failure: results from the HF-ACTION Study

Conference EUROPEAN HEART JOURNAL · September 1, 2010 Link to item Cite

Evidence for collagen type XXIV as a modifier of survival after heart failure

Conference CIRCULATION · October 25, 2005 Link to item Cite

Gene expression profile in circulating leukocytes identifies patients with coronary artery disease

Conference JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY · February 1, 2005 Link to item Cite

PPAR17 polymorphism is associated with reduced cardiac function identifying it as a modifier of heart failure

Conference CIRCULATION · October 26, 2004 Link to item Cite

An association between COL24A1 and ejection fraction in a human heart failure population: Evidence supporting COL24A1 as a modifier gene in human heart failure

Conference CIRCULATION · October 26, 2004 Link to item Cite

Proteomic discovery of coronary artery disease proteins using industrial scale analysis of pooled plasma: Results from the pooled plasma proteomics project

Conference CIRCULATION · October 26, 2004 Link to item Cite

Identification of COL24A1 as a novel candidate gene for heart failure in mice and humans

Conference AMERICAN JOURNAL OF HUMAN GENETICS · November 1, 2003 Link to item Cite

Collagen XXIV, alpha 1: A novel candidate gene for the modification of heart failure outcome in both mice and humans

Conference CIRCULATION · October 28, 2003 Link to item Cite